ヘリコバクター・パイロリ感染症と慢性疾患との関連:心臓血管疾患,MASLD,および2型糖尿病に焦点を当てた
Navid Maleki1, Alireza Mohammadzadeh2, Jalal Mardaneh2
1Student Research Committee, Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
Metabolism open
|September 2, 2025
まとめ
ヘリコバクター・パイロリ感染症は,心血管疾患,代謝機能不全に関連した脂肪酸性肝疾患,および2型糖尿病と関連しています. H. pyloriを根絶することは,これらの慢性疾患の修正可能な危険因子である可能性があります.
科学分野:
- 胃腸科 と 感染症
- 心臓病科
- ヘパトロジー
- 内分泌学
背景:
- ヘリコバクター・パイロリ (H. pylori) は広範囲にわたる胃腸病原体である.
- 新興の証拠は,H. pyloriと胃外非伝染性疾患 (NCD) を関連付けています.
研究 の 目的:
- H. pylori 感染と慢性疾患の流行病学的およびメカニズム的関連性を検討する.
- H. pylori と心血管疾患 (CVD),代謝機能障害関連脂肪性肝疾患 (MASLD),および2型糖尿病 (T2DM) の関連性を調査する.
主な方法:
- 疫学研究から得られた証拠の統合
- NCDにおけるH. pyloriの役割を調査するメカニズム的研究のレビュー.
主要な成果:
- H. pyloriは慢性的な炎症と内皮機能障害によってCVDを悪化させる可能性があります.
- H. pyloriはインスリン抵抗性や肝炎によってMASLDに関与しているが,結果は異なる.
- 炎症体,ホルモン,免疫遺伝子が関与する経路は,T2DMにおけるH. pyloriの役割を示唆しています.
結論:
- H. pylori の感染は,いくつかの NCD と関連しています.
- H. pyloriは,NCDの変更可能な危険因子である可能性があります.
- H. pyloriの根絶に関する介入研究を含むさらなる研究が,因果関係を確認するために必要である.
さらに関連する動画
関連する概念動画
01:30Peptic Ulcer Disease I: Introduction
285
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
285
01:17Gastritis-II: Pathophysiology
542
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
542
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
523
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
523
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
700
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
700
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:28Peptic Ulcer Disease II: Pathophysiology
827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827